REGN: Bull Flag detected on 14 Jul 2026
All prices, scores, and news on this page reflect data available before market open on .
Browse all Bull Flag detections →On 14 Jul 2026, our scan flagged REGN as a bull flag setup scoring 75 out of 98 (Good tier), with a 75% win probability based on our historical pattern database and a 2.3 to 1 reward to risk ratio. This is a swing trade setup: win probability reflects a 10 trading day hold, not an intraday move. At $663.09, the conservative target is $684.97 with a stop at $626.62.
Overall Score
75
of 98
Good
Win Probability
75%
High
Reward / Risk
2.3
: 1
$11.37 reward
$-5.00 risk
Swing Trading Plan
Entry
$663.09
Target
$684.97
Stop Loss
$626.62
Holding Period
Up to 10 trading days
Win Probability
75%
Current Setup
REGN is forming a bull flag pattern with a structure score of 14.2, indicating tight consolidation after the recent 10.21% one-month rally. The flag is anchored between 655.11 (key support) and 677.92 (key resistance), with the current price at 663.09. The breakout score of 11.7 and volume score of 11.4 reveal below-average volume confirmation during the consolidation phase (current volume at 604,975 vs. 20-day average of 1,006,088, volume ratio of 0.6). The 58.62 RSI shows moderate momentum without overbought conditions. The overall score of 75.3 and 74.81% win probability suggest a solid technical setup despite volume weakness.
Stock Context
Regeneron will report Q2 2026 financial results on July 30, 2026 before market open, 16 days from the pattern detection date. Q1 2026 results showed revenue of $3.61 billion, up 19% year-over-year, though EPS fell to $6.99 from $7.58 and net income declined 10%. Recent catalysts include FDA approvals expanding Dupixent to children aged 2-11 with chronic spontaneous urticaria and accelerated approval for Otarmeni, a gene therapy for hearing loss. In April 2026, REGN secured government pricing agreements with Most-Favored-Nation pricing and tariff relief for three years. The Health Care sector regime is bullish (0.83 score), providing favorable momentum. However, the analyst price target recently adjusted to $875.31, suggesting modest upside expectations from current levels.
What to Expect
A successful breakout above the 677.92 resistance would target the measured move of 684.97 (conservative target), with potential extension toward the $875 analyst consensus level. The pattern's 74.81% win probability suggests favorable odds, but volume confirmation remains critical—the current 0.6 volume ratio must expand above the 20-day average to validate the breakout. Invalidation occurs at the 655.11 support level; a close below this level breaks the flag structure and signals pattern failure. The moderate 2.4% ATR suggests controlled volatility, suitable for disciplined position management.
Risk Factors
Earnings on July 30, 2026 represent immediate binary risk just 16 days away; historical data shows REGN averaged -0.35% on earnings announcement days. The 19.03% drawdown from 52-week highs indicates recent underperformance that could reflect unresolved concerns. Short positioning is relatively low, limiting squeeze potential but also suggesting limited institutional urgency. The bearish market regime score of -0.26 conflicts with the bullish sector backdrop, creating cross-current headwinds. Volume remains the critical weakness—at 0.6 relative volume, breakout credibility depends on volume expansion. Low beta (0.17) limits volatility, which can compress both upside and downside moves. Macro deterioration or sector rotation out of Healthcare could quickly reverse the favorable sector momentum that's partially driving this setup.
Sources:
REGENERON PHARMACEUTICALS, INC. - Form 8-K - FY2026
·
REGENERON PHARMACEUTICALS, INC. - Form 8-K - FY2026
·
Regeneron to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast | Regeneron Pharmaceuticals Inc.
·
Regeneron Q2 2026 results set for July 30 | REGN Stock News
·
Regeneron to Report First Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on April 29, 2026 | Regeneron Pharmaceuticals Inc.
·
Regeneron Pharmaceuticals (Nasdaq:REGN) - Stock Analysis - Simply Wall St
·
Does Regeneron’s Gene Therapy Milestone and Buyback Shift the Bull Case For Regeneron Pharmaceuticals (REGN)? - Simply Wall St News
·
Investor Relations | Regeneron Pharmaceuticals Inc.
How We Find and Score This Setup
We scan more than 6,000 NYSE and NASDAQ stocks every trading day and compare each detected pattern against a database of 370,000+ historical detections. Every setup is scored across three dimensions: Structure, Volume, and Breakout Readiness. Win probability is a calibrated estimate of how similar historical setups performed over the following 10 trading days. This is a swing trading tool built for multi-day holds. It is not built or tested for day trading.
Frequently Asked Questions
Is REGN a good swing trade?
REGN scored 75 out of 98 on our bull flag scan, with a 75% historical win probability over the standard 10 trading day hold. Good setup based on our systematic scoring.
What is the entry, target, and stop loss for this setup?
The setup's reference price is $663.09, with a conservative target of $684.97 and a stop loss at $626.62.
What would invalidate this bull flag setup?
A close below the stop loss at $626.62 would invalidate the setup and suggest the pattern has failed.
How is the win probability calculated?
Win probability is a calibrated estimate of how similar historical bull flag setups performed over the following 10 trading days, drawn from a database of 370,000+ historical pattern detections across 6,000+ NYSE and NASDAQ stocks.
Market & Sector Regime
Market
Bearish
-0.26
-1.0
0
+1.0
Health Care Sector
Bullish
0.83
-1.0
0
+1.0
Overall Score
37
of 40
Pattern Quality
14
of 20
Setup
13
of 20
R/R
11
of 18
Context
Pattern Quality Score
14
of 15
Structure
12
of 13
Breakout
11
of 12
Volume
Recent Performance
Momentum & Trend
RSI (14)
58.6
Neutral
MACD Histogram
+6.04
Strong Bullish
Bollinger Band Position
81.6%
Upper Zone
Volatility & Risk
20-Day Volatility
0.26
Moderate
ATR %
2.4%
Medium
Beta
0.17
Defensive
Volume Analysis
Volume Ratio
0.60x
Below Avg
20-Day Avg Vol
1.0M
shares / day
Current Volume
605K
shares traded
Price Levels
52W High
$818.93
Target
$684.97
Resistance
$677.92
Current
$663.09
Support
$655.11
Stop Loss
$626.62
52W Low
$516.10
Disclaimer: This analysis is algorithmically generated for educational purposes only and does not constitute financial advice. Past pattern performance does not guarantee future results. Win probabilities are based on historical data across 370,000+ observations. Always conduct your own research and consult a qualified financial advisor. AI-assisted contextual analysis by Claude (Anthropic). Indicators reflect values at time of detection.